Aura Biosciences, Inc.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It deve…
Biotechnology
US, Cambridge [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Aura Biosciences, Inc.'s gradings, price targets and earnings estimates. None
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2023 | -1.9100 | -1.842 | 0 | 0 | -57 | -72 | -59 | 0 | -61 | 0 | 18 | 0 |
| 2024 | -1.9300 | -1.675 | 0 | 0 | -76 | -66 | -83 | 0 | -86 | 0 | 19 | 0 |
| 2025 | - | -2.045 | - | 18 | - | -85 | - | 0 | - | 0 | - | 0 |
| 2026 | - | -2.133 | - | 19 | - | -84 | - | 0 | - | 0 | - | 0 |
| 2027 | - | -2.570 | - | 17 | - | 1.F4X/td> | - | 1.F41/td> | - | 1.F41 | - | 1.F41 |
| 2028 | - | -1.655 | - | 109 | - | 0.F5X/td> | - | 0.F51/td> | - | 0.F51 | - | 0.F51 |